Cedar Brook Financial Partners, LLC Ab Cellera Biologics Inc. Transaction History

Cedar Brook Financial Partners, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 12, 2024	BUY	$3.91 - $5.93 $36,824 - $55,848	9,418 Added 31.13%	39,668 $226,000
Q3 2023 Oct 17, 2023	BUY	$4.6 - $7.95 $23,000 - $39,750	5,000 Added 19.8%	30,250 $139,000
Q2 2023 Jul 05, 2023	BUY	$5.66 - $7.59 $7,273 - $9,753	1,285 Added 5.36%	25,250 $163,000
Q4 2022 Feb 01, 2023	BUY	$9.48 - $14.52 $18,960 - $29,040	2,000 Added 9.11%	23,965 $242,000
Q3 2022 Jan 03, 2023	BUY	$9.2 - $13.68 $9,200 - $13,680	1,000 Added 4.77%	21,965 $217,000
Q2 2022 Aug 12, 2022	BUY	$5.72 - $10.65 $22,880 - $42,600	4,000 Added 23.58%	20,965 $223,000
Q1 2022 Apr 06, 2022	BUY	$7.46 - $14.14 $39,165 - $74,235	5,250 Added 44.81%	16,965 $165,000
Q4 2021 Jan 27, 2022	BUY	$12.99 - $17.73 $152,177 - $207,706	11,715 New	11,715 $168,000

155

109M

153K

194K

Ticker ABCL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 285,139,008
Market Cap $807M
Description
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...

Get notified when there are updates to the investment portfolio of Cedar Brook Financial Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Cedar Brook Financial Partners, LLC with notifications on news.